Our January 2015 installment in the ongoing "New Frontiers in Prostate Cancer" series focuses on the challenges presented by high-risk disease. Here are some video resources on high-risk prostate cancer.
Our January 2015 installment in the ongoing "New Frontiers in Prostate Cancer" series focuses on the challenges presented by high-risk disease. Here are some video resources on high-risk prostate cancer.
1. Treating high-risk localized prostate cancer (OncLive)
Next: New data on RT in high-risk prostate cancer
2. New data on RT in high-risk prostate cancer (MedPage Today)
3. Two genes together drive aggressive prostate cancer (Columbia University Medical Center)
Subscribe to Urology Times to get monthly news from the leading news source for urologists.
Phase 1B trial to evaluate relugolix and enzalutamide in high-risk prostate cancer
July 24th 2024"Going forward after this study, we hope to be able to expand and potentially look at patients undergoing either surgery or radiation therapy, and really try to determine the potential benefit," says Kelly L. Stratton, MD, FACS.